ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.91
0.06%
US Tech 100
18,243.60
0.26%
S&P 500
5,321.41
0.25%
US Dollar vs CAD
1.36364
-0.03%
Bitcoin
69,927.40
-0.29%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ambrx Biopharma Inc (AMAM)

  7. Ambrx Biopharma Inc (AMAM) News

AMAM

Ambrx Biopharma (AMAM)

Ambrx Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AMAM
DateTimeSourceHeadlineSymbolCompany
03/18/20241:45PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:AMAMAmbrx Biopharma Inc
03/12/20243:55PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMAMAmbrx Biopharma Inc
03/10/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AMAMAmbrx Biopharma Inc
03/08/202412:39PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMAMAmbrx Biopharma Inc
03/08/202412:34PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMAMAmbrx Biopharma Inc
03/08/202412:29PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMAMAmbrx Biopharma Inc
03/08/202412:24PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMAMAmbrx Biopharma Inc
03/08/202412:20PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMAMAmbrx Biopharma Inc
03/07/202412:23PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AMAMAmbrx Biopharma Inc
03/07/20247:49AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMAMAmbrx Biopharma Inc
03/06/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMAMAmbrx Biopharma Inc
02/23/20241:09PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMAMAmbrx Biopharma Inc
02/22/20247:31AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMAMAmbrx Biopharma Inc
02/22/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMAMAmbrx Biopharma Inc
02/12/202412:43PMPR Newswire (US)Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law FirmNASDAQ:AMAMAmbrx Biopharma Inc
01/10/20242:07PMPR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:AMAMAmbrx Biopharma Inc
01/08/20241:54PMDow Jones NewsTrending: Johnson & Johnson and Merck & Co. Announce AcquisitionsNASDAQ:AMAMAmbrx Biopharma Inc
01/08/20249:04AMDow Jones NewsAmbrx Biopharma Shares Double on $2 Billion Acquisition by Johnson & JohnsonNASDAQ:AMAMAmbrx Biopharma Inc
01/08/20247:12AMDow Jones NewsJohnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2 BillionNASDAQ:AMAMAmbrx Biopharma Inc
10/23/20234:19PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:AMAMAmbrx Biopharma Inc
09/15/20233:27PMEdgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AMAMAmbrx Biopharma Inc
09/15/20233:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMAMAmbrx Biopharma Inc
09/06/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMAMAmbrx Biopharma Inc
08/25/20234:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMAMAmbrx Biopharma Inc
07/19/20238:49AMDow Jones NewsAmbrx Biopharma Gets Fast Track Designation for ARX517 Cancer TreatmentNASDAQ:AMAMAmbrx Biopharma Inc
06/28/20233:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMAMAmbrx Biopharma Inc
06/28/20233:45PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AMAMAmbrx Biopharma Inc
06/28/20233:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMAMAmbrx Biopharma Inc
06/28/20233:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMAMAmbrx Biopharma Inc
06/09/20233:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMAMAmbrx Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:AMAM

Your Recent History

COIN
DATGBP
Datum
USOTC
AMTCF
A Metaverse (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved